Challenge Cancer Support Network Inc
About
Challenge Cancer Support Network Inc is a large registered charity based in West Melbourne, VIC. It serves: first nations, children, early childhood, ethnic groups, families, females, financially disadvantaged, males, chronic illness, disability, rural & remote, unemployed, youth.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $3.3M | $2.9M | $11.2M | $506K |
| 2022 | $2.5M | $1.9M | $10.3M | $686K |
| 2021 | $2.2M | $1.4M | $9.8M | $735K |
| 2020 | $2.8M | $2.4M | $8.7M | $399K |
| 2019 | $3.1M | $2.5M | $8.2M | $601K |
| 2018 | $2.4M | $2.1M | $7.5M | $221K |
| 2017 | $2.5M | $2.4M | $7.3M | $76K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-31030070820
- ABN
- 31030070820
- Website
- challenge.org.au
- Financial Year
- 2023
Focus Areas
Board & Leadership (7)
- board member
- board member
- chair
- chair
- officeholder
- public officer
- secretary
Financials
- Revenue
- $3.3M
- Assets
- $11.2M
Method
- Match Confidence
- registry
- Cross-references
- 1 dataset
- Match Key
- ABN
- Relationships
- 28
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
JusticeHub
External LinkThis entity is also tracked in JusticeHub with 0 interventions and 0 evidence records.
External ecosystem profile linked from GrantScope for additional context. JusticeHub content is maintained separately.
View on JusticeHubLocation Intelligence
- Postcode
- 3003
- Locality
- WEST MELBOURNE
- Remoteness
- Major Cities of Australia
- SEIFA Disadvantage
- Decile 8/10
- LGA
- Melbourne
- SA2 Region
- West Melbourne - Industrial
- Entities in Area
- 174
Disability Market Context
NDIS LayerThis organisation shows disability-related delivery signals. The strategic question is whether it sits inside a resilient market, a thin market, or a captured market where large providers take most of the money and local alternatives are scarce.